Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Emily Williams

Physician Assistant Southington, CT Physician Assistant

NPI 1144873225 CMS profile 11190164

167 Main St, Southington, CT 06489

Open in the dashboard

General payments

$166

8 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Emily Williams of Southington, CT is reported in the CMS Open Payments database as having received $166 across 8 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 35th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $55 1
2022 General $18 1
2021 General $92 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Emily Williams
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Emily Williams were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Emily Williams Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $92 $132 $37–$438 $132
2022 $18 $155 $48–$522 $149
2023 $0 $167 $52–$557 $160
2024 $55 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Inspire Medical Systems, Inc. $55 1 payment
  2. Pfizer Inc. $35 2 payments
  3. GlaxoSmithKline, LLC. $27 2 payments
  4. Salix Pharmaceuticals, a division of Bausch Health US, LLC $23 1 payment
  5. Lilly USA, LLC $14 1 payment
  6. Amgen Inc. $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $166 8 payments
Products named General payments · program years 2021–2024
  1. INSPIRE $55 1 payment
  2. ELIQUIS $35 2 payments
  3. NUCALA $27 2 payments
  4. XIFAXAN $23 1 payment
  5. COLOGUARD DNA CAPTURE REAGENTS $17 1 payment
  6. EMGALITY $14 1 payment
  7. REYVOW $14 1 payment
  8. AIMOVIG $12 1 payment
  9. Repatha $12 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 65 drugs

Part D claims

2,382

Median for Physician Assistant: 241

Drug cost

$267,982

Median for Physician Assistant: $4,110

Branded share of claims

17.7%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ozempic Semaglutide Brand 51 $50,537
Jardiance Empagliflozin Brand 31 $41,830
Eliquis Apixaban Brand 39 $39,005
Mounjaro Tirzepatide Brand 28 $28,954
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter Brand 40 $28,740
Prolia Denosumab Brand 12 $20,853
Xarelto Rivaroxaban Brand 17 $15,103
Januvia Sitagliptin Phosphate Brand 18 $14,644
Synthroid Levothyroxine Sodium Brand 25 $3,434
Wixela Inhub Fluticasone Propion/Salmeterol Brand 21 $2,314

The 10 drugs with the highest cost, of 65 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$36,151

Of which drugs: $6,360

Medicare patients

216

Average age 74

Services billed

571

129 women, 87 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 49%
Diabetes 24%
Depression 22%
Ischemic heart disease 21%
Atrial fibrillation 21%
Cancer 18%
COPD 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Pcv20 vaccine im 90677 Office 11 11 $3,195
Vaccine for influenza for injection into muscle 90662 Office 23 23 $1,882

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

8 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record